Investors seeking a blend of capital appreciation and passive income generation can find what they're looking for right now in the healthcare sector. Wall Street analysts who follow a real estate investment trust and one of the world's largest pharmaceutical companies think they aren't getting as much attention as they deserve.

In addition to yields that are way above average, the price targets investment bank analysts pinned to these stocks suggest they can climb 29% and 24% over the next 12 months.

Before you fill your portfolio with these dividend stocks, it's important to realize that investment bank analysts who set lofty price targets can simply adjust those targets downward if things don't work out later.

Continue reading

Source Fool.com